In AD patients, there is amyloid-β (Aβ) plaque deposition derived from the amyloid precursor protein (APP), which may progressively lead to tau pathology and the deterioration of brain circuit functions and cellular degeneration over several years (Sasaguri et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.